Pro- and prebiotics - The tasty guardian angels?

Applied Microbiology and Biotechnology

Volumn 55, Issue 1, 2001, Pages 19-28

  Simmering, R ^a   Blaut, M ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT;

BIFIDOBACTERIUM; BIOTECHNOLOGY; GASTROINTESTINAL TRACT FUNCTION; INTESTINE FLORA; LACTOBACILLUS; NONHUMAN; NUTRITIONAL SCIENCE; SHORT SURVEY;

BIFIDOBACTERIUM; BIOTECHNOLOGY; ECOSYSTEM; HUMANS; INTESTINES; LACTOBACILLUS; PROBIOTICS;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; LACTOBACILLUS; MICROBIOTA;

EID: 0035098935     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002530000512     Document Type: Short Survey

References (158)

1. Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat
2. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model
3. Persistence of colonization of human colonic mucosa by a probiotic strain, Lactobacillus rhamnosus GG, after oral consumption
4. Effect of transgalacto-oligosaccharides on the composition of the human intestinal microflora and on putative risk markers for colon cancer
5. Antagonistic effect of Enterococcus faecium J96 against human and poultry pathogenic Salmonella spp
6. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri
7. Phylogenetic relationships of butyrate-producing bacteria from the human gut
8. Colonic food: Pre- and probiotics
9. Probiotics, prebiotics or 'conbiotics'?
10. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions
11. The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo
12. An electron microscopy study of the adherence of Bifidobacterium bifidum to human intestinal Caco-2 cells in vitro
13. The use of probiotics in the diet of dogs
14. Isolation and characterization of two bacteriocins of Lactobacillus acidophilus LF221
15. Effects of Bifidobacterium sp. fermented milk ingested with or without inulin on colonic bifidobacteria and enzymatic activities in healthy humans
16. Administration of transgalacto-oligosaccharides increases fecal bifidobacteria and modifies colonic fermentation metabolism in healthy humans
17. Protective cultures inhibit growth of Listeria monocytogenes and Escherichia coli O157:H7 in cooked, sliced, vacuum- and gas-packaged meat
18. Dietary supplement of neosugar alters the fecal flora and decreases activities of some reductive enzymes in human subjects
19. Selected indigestible oligosaccharides affect large bowel mass, cecal and fecal short-chain fatty acids, pH and microflora in rats
20. PCR methods for identification and specific detection of probiotic lactic acid bacteria
21. Distribution of pathogen inhibition in the Lactobacillus isolates of a commercial probiotic consortium
22. Protein-mediated adhesion of Lactobacillus acidophilus BG2FO4 on human enterocyte and mucus-secreting cell lines in culture
23. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion
24. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB
25. Antagonistic activity of Lactobacillus acidophilus LB against intracellular Salmonella enterica serovar Typhimurium infecting human enterocyte-like Caco-2/TC-7 cells
26. Probiotics, prebiotics, and synbiotics: Approaches for modulating the microbial ecology of the gut
27. Use of luciferase genes as biosensors to study bacterial physiology in the digestive tract
28. Effect of soluble or partly soluble dietary fibres supplementation on absorption and balance of calcium, magnesium, iron and zinc in healthy young men
29. Adhesion of different bifidobacteria strains to human enterocyte-like Caco-2 cells and comparison with in vivo study
30. Production of probiotic cheese (cheddar-like cheese) using enriched cream fermented by Bifidobacterium infantis
31. In vitro biodegradation study of acetyl and methyl inulins by Bifidobacteria and inulinase
32. Ingredient supplementation effects on viability of probiotic bacteria in yogurt
33. Evaluation of the effect of 3 probiotics on experimental Escherichia coli enterotoxaemia in weaned piglets
34. Effect of fermentable fructo-oligosaccharides on mineral, nitrogen and energy digestive balance in the rat
35. Inhibition of Listeria monocytogenes in a pork product by a Lactobacillus sake strain
36. Inhibition of bacterial pathogens by lactobacilli
37. Compared effects of three oligosaccharides on metabolism of intestinal microflora in rats inoculated with a human faecal flora
38. Modulation of nonspecific mechanisms of defense by lactic acid bacteria: Effective dose
39. Design and evaluation of a 16S rRNA-targeted oligonucleotide probe for specific detection and quantitation of human faecal Bacteroides populations
40. Inhibition of in vitro growth of enteropathogens by new Lactobacillus isolates of human intestinal origin
41. The bacterial flora of the stomach and small intestine
42. Probiotics: From myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials
43. Inhibition of Listeria monocytogenes in a smear-surface soft cheese by Lactobacillus plantarum WHE 92, a pediocin AcH producer
44. Normal indigenous intestinal flora
45. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes
46. Effects of a mixture of organisms Lactobacillus acidophilus or Streptococcus faecalis on cholesterol metabolism in rats fed on a fat- and cholesterol-enriched diet
47. Effect of a probiotic formula on intestinal immunoglobulin A production in healthy children
48. Effect of bifidobacteria feeding on fecal flora and production of immunoglobulins in lactating mouse
49. Probiotics in man and animals
50. Probiotics in human medicine
51. Modification of the intestinal microflora using probiotics and prebiotics
52. Use of green fluorescent protein to tag lactic acid bacterium strains under development as live vaccine vectors
53. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin
54. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics
55. Enrichment of bifidobacteria from human gut contents by oligofructose using continuous culture
56. Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin
57. Generation of DNA probes for detection of microorganisms by polymerase chain reaction fingerprinting
58. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019)
59. Review of probiotics available to modify gastrointestinal flora
60. Cell surface-associated lipoteichoic acid acts as an adhesion factor for attachment of Lactobacillus johnsonii La1 to human enterocyte-like Caco-2 cells
61. Factors involved in adherence of lactobacilli to human Caco-2 cells
62. PCR primers and probes for the 16S rRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid
63. A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization
64. Oligofructose stimulates calcium absorption in adolescents
65. The role of lactic acid bacteria in colon cancer prevention: Mechanistic considerations
66. Use of Aviguard and other intestinal bioproducts in experimental Clostridium perfringens-associated necrotizing enteritis in broiler chickens
67. Human fecal flora: Variation in bacterial composition within individuals and a possible effect of emotional stress
68. Lactic acid bacteria and the human gastrointestinal tract
69. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection
70. Effects of transgalactosylated disaccharides on the human intestinal microflora and their metabolism
71. Preventive role of lyophilic dairy products bulgaricum and biostim
72. Screening of probiotic activities of forty-seven strains of Lactobacillus spp by in vitro techniques and evaluation of the colonization ability of five selected strains in humans
73. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model
74. Lactic acid bacterium potently induces the production of interleukin-12 and interferon-gamma by mouse splenocytes
75. Identification and quantification of Bifidobacterium species isolated from food with genus-specific 16S rRNA-targeted probes by colony hybridization and PCR
76. Lactobacilus acidophilus as a dietary adjunct for milk to aid lactose digestion in humans
77. Analysis of fecal populations of bifidobacteria and lactobacilli and investigation of the immunological responses of their human hosts to the predominant strain
78. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons
79. Taxonomy and physiology of probiotic lactic acid bacteria
80. Oligofructose modulates lipid metabolism alterations induced by a fat-rich diet in rats
81. Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces
82. Effects of inulin on faecal bifidobacteria in human subjects
83. Quantitative fluorescence in situ hybridization of Bifidobacterium spp with genus-specific 16S rRNA-targeted probes and its application in fecal samples
84. Prolonged intake of fructo-oligosaccharides induces a short-term elevation of lactic acid-producing bacteria and a persistent increase in cecal butyrate in rats
85. Review article: The use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease
86. Immunomodulation of the gnotobiotic mouse through colonization with lactic acid bacteria
87. Comparative biochemical and immunological study of malic enzyme from two species of lactic acid bacteria: Evolutionary implications
88. Specific detection of a probiotic Lactobacillus strain in faecal samples by using multiplex PCR
89. PCR-based preparation of 23S rRNA-targeted group specific polynucleotide probes
90. Probiotics: A novel approach in the management of food allergy
91. Investigations of bifidobacterial ecology and oligosaccharide metabolism in a three-stage compound continuous culture system
92. A probiotic strain of L. acidophilus reduces DMH-induced large intestinal tumors in male Sprague-Dawley rats
93. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria
94. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria
95. Effect of fructo-oligosaccharides on intestinal microflora
96. Effect of probiotic supplementation on serum/yolk cholesterol and on egg shell thickness in layers
97. Effect of probiotic supplementation on growth, nitrogen utilisation and serum cholesterol in broilers
98. Human fecal flora: The normal flora of 20 Japanese-Hawaiians
99. Fermentation of fructans by epiphytic lactic acid bacteria
100. DGGE/TGGE a method for identifying genes from natural ecosystems
101. Probiotic spectra of lactic acid bacteria (LAB)
102. Monoassociation with Lactobacillus acidophihts UFV-H2b20 stimulates the immune defense mechanisms of germfree mice
103. Effects of fructo-oligosaccharides on the absorption of magnesium and calcium by cecectomised rats
104. Effects of fructo-oligosaccharides on the absorption of iron, calcium, and magnesium in iron deficient anemic rats
105. Inhibition of Listeria monocytogenes by plantaricin NA an antibacterial substance from Lactobacillus plantarum
106. Characterization of lactic acid bacteria isolated from a Thai low-salt fermented fish product and the role of garlic as substrate for fermentation
107. Lactobacillus salivarius CTC2197 prevents Salmonella enteritidis colonization in chickens
108. The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females
109. Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immuno-stimulatory effect in healthy subjects
110. Enhancement of immune response in mice fed with Streptococcus thermophilus and Lactobacillus acidophilus
111. Prevention of gastrointestinal infection using immunobiological methods with milk fermented with Lactobacillus casei and Lactobacillus acidophilus
112. Immunoadjuvant activity of oral Lactobacillus casei: Influence of dose on the secretory immune response and protective capacity in intestinal infections
113. Immune system stimulation by probiotics
114. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria
115. Lactase malabsorption in children with symptomatic Giardia lamblia infection
116. Reduction of rotavirus infection in children receiving bifidobacteria-supplemented formula
117. Antigenotoxic properties of lactic acid bacteria in vivo in the gastrointestinal tract of rats
118. Probiotic fermented food mixtures: Possible applications in clinical anti-diarrhoea usage
119. Dose-response effects of inulin and oligofructose on intestinal bifidogenesis effects
120. Prevention of colon cancer by pre- probiotics: Evidence from laboratory studies
121. Possible mechanisms by which pro- and prebiotics influence colon carcinogenesis and tumor growth
122. Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition
123. Functional effects of food components and the gastrointestinal system: Chicory fructooligosaccharides
124. Prebiotics and synbiotics: Concepts and nutritional properties
125. Dietary fructans
126. The bitidogenic nature of chicory inulin and its hydrolysis products
127. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: A review of papers published between 1988 and 1998
128. Autoaggregation of Lactobacillus reuteri is mediated by a putative DEAD-box helicase
129. Genus- and species-specific PCR-based detection of dairy propionibacteria in environmental samples by using primers targeted to the genes encoding 16S rRNA
130. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced aberrant crypt foci in rats
131. Molecular identification of potentially probiotic lactobacilli
132. Clinical uses of probiotics for stabilizing the gut mucosal barrier: Successful strains and future challenges
133. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria
134. Immune modulation of blood leukocytes in humans by lactic acid bacteria: Criteria for strain selection
135. Behaviour of Listeria monocytogenes in meat and its control by a bacteriocin-producing strain of Lactobacillus sake
136. Quantification of different Eubacterium spp in human fecal samples with species-specific 16S rRNA-targeted oligonucleotide probes
137. Quantification of the flavonoid-degrading bacterium Eubacterium ramulus in human fecal samples with a species-specific oligonucleotide hybridization probe
138. Bifidobacterium longum, a lactic acid-producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis
139. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut
140. Role of human microflora in health and disease
141. Development of a direct in situ PCR method for detection of specific bacteria in natural environments
142. Proinflammatory cytokine and nitric oxide induction in murine macrophages by cell wall and cytoplasmic extracts of lactic acid bacteria
143. Effects of lactic acid bacteria ingestion of basal cytokine mRNA and immunoglobulin levels in the mouse
144. Biotechnologische verfahren zur herstellung von lebensmitteln und futtermitteln
145. Strain-specific identification of probiotic Lactobacillus rhamnosus with randomly amplified polymorphic DNA-derived PCR primers
146. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures
147. Functional food properties of non-digestible oligosaccharides: A consensus report from the ENDO project (DGXII AIRII-CT94-1095
148. Functionality of probiotics and intestinal lactobacilli: Light in the intestinal tract tunnel
149. Characterization of bifidobacteria by random DNA amplification
150. Molecular tools for analyzing the functionality of probiotic properties of microorganisms
151. Effects of the in vitro fermentation of oligofructose and inulin by bacteria growing in the human large intestine
152. 16S ribosomal RNA-targeted oligonucleotide probes for monitoring of intestinal tract bacteria
153. Immunogenicity of cell wall and plasma membrane components of some oral lactic acid bacteria
154. Effects of inulin on lipid parameters in humans
155. Human colonic biota studied by ribosomal DNA sequence analysis
156. Immunomodulatory function of lactic acid bacteria
157. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria